Kevin M. Brown
National Institutes of Health(US)QIMR Berghofer Medical Research Institute(AU)National Jewish Health(US)Philips (United States)(US)National Cancer Institute(US)Interstitial Cystitis Association(US)Division of Cancer Epidemiology and GeneticsColumbia University(US)Virginia Tech(US)University of Colorado Denver(US)Brookhaven College(US)
Publications by Year
Research Areas
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, melanin and skin pigmentation, Melanoma and MAPK Pathways, Sarcoidosis and Beryllium Toxicity Research, Genetic Associations and Epidemiology
Most-Cited Works
- → An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management(2011)7,219 cited
- → Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis(2014)4,517 cited
- → An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias(2013)4,194 cited
- → Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline(2018)4,017 cited
- → Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report(2016)1,408 cited
- → A Common MUC5B Promoter Polymorphism and Pulmonary Fibrosis(2011)1,192 cited